Dexcom (DXCM) Net Cash Flow (2010 - 2026)

Dexcom (DXCM) has 17 years of Net Cash Flow data on file, last reported at $202.1 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $202.1 million, down 31.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $195.9 million (up 256.18% YoY), and the FY2025 annual result was $290.3 million, up 515.04% from the prior year.
• Net Cash Flow climbed to $202.1 million in Q1 2026 per DXCM's latest filing, from -$921.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $677.7 million in Q3 2025 and troughed at -$921.6 million in Q4 2025.
• A 5-year average of $3.4 million and a median of -$3.9 million in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 2331.78% in 2023, then sank 23530.77% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$62.6 million in 2022, then slumped by 33.23% to -$83.4 million in 2023, then soared by 95.32% to -$3.9 million in 2024, then slumped by 23530.77% to -$921.6 million in 2025, then surged by 121.93% to $202.1 million in 2026.
• Business Quant data shows DXCM's Net Cash Flow at $202.1 million in Q1 2026, -$921.6 million in Q4 2025, and $677.7 million in Q3 2025.